Share this page

 CAIRI — 2046293

Toolbar

Toolbar

Details

Third-party disclaimer

Share this page

No endorsement of any products or services is expressed or implied.

Third-party disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Application number

2046293

Registration number

TMA1165620

Type(s)

Standard Characters

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2020-08-18

Registered

2023-02-15

Registration Expiry Date

2033-02-15

Registered Owner

Mylan Pharmaceuticals, Inc.
781 Chestnut Ridge Road
Morgantown, WV 26505
UNITED STATES OF AMERICA

Agent

OSLER, HOSKIN & HARCOURT LLP
Suite 320, World Exchange Plaza
100 Queen Street
Ottawa,
ONTARIO K1P1J9

Documents

View documents

Index headings

  • CAIRI

Goods (Nice class & Statement)

5
(1) Pharmaceutical preparations for the treatment of diabetes.

Action History

Actions
Action Action date Due date Comments
Filed 2020-08-18
Created 2020-08-18
Formalized 2020-08-18
Pre-Assessment Letter Sent 2022-04-20 Acceptable Goods or Services
Search Recorded 2022-10-25
Approved 2022-10-31 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2022-10-31 APPROVED BY PROGRAM EX200M1
Advertised 2022-11-23 Vol.69 Issue 3552
Registration Pending 2023-02-15
Registered 2023-02-15 2033-02-15
Report a problem on this page
Date modified: